<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3148700/" ref="ordinalpos=4919&amp;ncbi_uid=3449436&amp;link_uid=PMC3148700" image-link="/pmc/articles/PMC3148700/figure/F4/" class="imagepopup">Figure 4. From: Calcium Mediates Glomerular Filtration through Calcineurin and mTORC2/Akt <span class="highlight" style="background-color:">Signaling</span>. </a></div><br /><div class="p4l_captionBody">Protamine sulfate activates signaling through the calcineurin pathway. (A) Western blots show treatment with 600 μg/ml PS reduces the amount of full-length (110 kD) Synpo present in glomerular lysates. Pretreatment with 10 μM E64 prevents this reduction in full-length Synpo. (B and C) Pretreatment with 24 μg/ml FK506 (B) or 50 μg/ml cyclosporine A (C) reduces PS-mediated glomerular injury. (D) Treatment with 10 μM CatL inhibitor E64 partially blocks albumin release upon PS treatment.</div></div>